---
schema_version: "secwatch.filing_event.v1"
accession: "0001062993-24-007571"
form_type: "8-K"
ticker: null
cik: "0001617765"
company_name: "EVOME MEDICAL TECHNOLOGIES INC."
filed_at: "2024-04-01T23:59:59+00:00"
generated_at: "2026-06-04T04:41:32.459624+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Evome Medical posts FY2023 preliminary revenue C$62.6M, positive Adj EBITDA C$852K

## Summary
- Revenue C$62.6M, gross margin C$22.5M (36% of sales); Adjusted EBITDA positive C$852K.
- CEO Seckler states turnaround completed after H1 losses; two consecutive quarters of positive Adj EBITDA.
- Full FY2023 financial statements (10-K) to be filed April 16, 2024.
- Plans to reduce debt by divesting non-core units; launched RST product; SpaceTek Knee expected late 2024.
- Fourth-quarter strength drove full-year positive EBITDA; first quarter 2024 improvements continuing.

## SEC filing metadata
- accession: 0001062993-24-007571
- form_type: 8-K
- cik: 0001617765
- company_name: EVOME MEDICAL TECHNOLOGIES INC.
- filed_at: 2024-04-01T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1617765/000106299324007571/0001062993-24-007571-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1617765/000106299324007571/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062993-24-007571
- JSON: https://secwatch.observer/filing/0001062993-24-007571.json
- Plain text: https://secwatch.observer/filing/0001062993-24-007571.txt

## Key facts
- Earnings Releases
  EVOME MEDICAL TECHNOLOGIES INC. reported preliminary financial results for the year ended December 31, 2023.
  - Period: the year ended December 31, 2023
  - Result: preliminary results
  source text: On April 1, 2024, Evome Medical Technologies Inc. issued a press release containing certain preliminary annual financial results for the year ended December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1617765/000106299324007571/0001062993-24-007571-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.